aPROMISE is intended to be used with PSMA images acquired using PET/CT imaging. The software provides a clinical application for oncology including detection and quantification of lesion candidates (in Bone, Lymph Node and Prostate).
Images shown for illustrative purposes only.
~29% and ~21% improved nodules detection
Riverain's AI suppression technology removes structures that can camouflage cancer and lung disease. 1,2
~26% and ~20% faster nodule search time
ClearRead CT technology helps radiologists see through the complexity to better detect abnormalities.1,2
Higher inter-reader agreement rates2
For CalanticTM software version 1.0.0 and older versions, no prior study will be examined.
Appropriate Series for CT
Photometric Interpretation (0028,0004) with value either MONOCHROME1 or MONOCHROME2
Intensities in Hounsfield units
Equally spaced slices, range 0.1 mm - 5.0 mm
Equally spaced pixels, range 0.1 mm - 2.0 mm
Appropriate Series for PET
Photometric Interpretation (0028,0004) with value MONOCHROME2
Equally spaced slices, range 1.4 mm - 5.0 mm
Equally spaced pixels, range 1.4 mm - 5.5 mm
Corrected Image (0028,0051) present with value ATTN or DECY
Decay Correction (0054,1102) present with value START
Units (0054,1001) present with value GML, CNTS, or BQML
Picture Archiving and Communications System (PACS) tools, clinical application for oncology including marking of regions of interest and quantitative analysis.
Currently not made available with Calantic Viewer. Separately distributed by Bayer.
EU risk class and CE marking
aPROMISE has CE marking (CE0123) and risk class IIa.
No contraindications given.
Trained healthcare professionals and researchers.
- Always ensure that the patient name, patient ID and study date displayed in the patient section correspond to the patient case you intend to review.
- The user must ensure the review of the image quality and quantification analysis results before signing the report.
- Always review the images and quantification results in the report to ensure that the information saved and exported is correct.
- The quantification analysis results provided by aPROMISE are intended to be used as complementary information together with other patient information and investigations used in the clinical decision making process. The user shall not rely solely on the information provided by aPROMISE for diagnostic or treatment decisions.